Position in NTRA
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,615,398
-$1,209,510 QoQ
Shares Held
5,951
-51.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#389
of 844 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026J. Safra Sarasin Holding AG holds $98,829,762 across 8 Diagnostics & Research names. NTRA ranks #5 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
174,160 | $33,173,995 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
61,179 | $30,672,703 | |
| 3 | A |
Agilent Technologies, Inc.
|
229,477 | $30,481,426 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
4,666 | $2,456,367 | |
| 5 | NTRA |
Natera, Inc.
This page
|
5,951 | $1,615,398 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,349 | $260,653 | |
| 7 | PSNL |
Personalis, Inc.
|
10,047 | $134,629 | |
| 8 | BIAF |
bioAffinity Technologies, Inc.
|
2,840 | $34,591 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,615,398 | 5,951 | Shares | Defined | 2026-07-31 | |
| 2025-12-31 | $2,824,908 | 12,331 | Shares | Defined | 2026-01-15 | |
| No filing history on record for this holder in this stock. | ||||||